CONTEXT: Despite the headline news that RWE shows no real improvement for mesothelioma patients, if you get down to the end of the article, there is promising news with the Continue Reading
CONTEXT: Another RWR study showing deficiencies in available biomarker testing, this time in Chronic lymphatic leukaemia patients. Biomarker driven care will give better outcomes for those patients with specific mutations Continue Reading
CONTEXT: Another commercial announcement of a tie up on RWD sources | US only. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 3 1. “Through the Continue Reading
CONTEXT: On the back of previous news stories about genetic biomarker testing in NSCLC, Neogenomics announces the launch of KRAS G12C testing to eligible advanced / late stage NSCLC cancer Continue Reading
CONTEXT: Commercial announcement of another pharmaceutical company securing access to RWD, in this case across oncology centres in France. IMPACT: Medium READ TIME: 1 min Quality Level Mean [1 – Continue Reading
CONTEXT: Commercially sponsored announcement of a retrospective study published in Journal of Urology looking at the impact of late luteinizing hormone-releasing hormone agonist dosing on testosterone suppression in patients with prostate Continue Reading
CONTEXT: Publication of a peer reviewed study in the ASCO journal showing RWE derived mortality data and the improvements this will confer in future study design endpoints and trial patient Continue Reading
CONTEXT: Opinion piece on RWE supporting the use of biosimilars in oncology. IMPACT: low READ TIME: 2 mins Quality Level Mean [1 – 10]: 6 1. “Providers and health care Continue Reading
CONTEXT: Report of a retrospective RWD study into the impact of race and ethnicity in oncology research. As we have reported here previously, there is an real issue with under-representation Continue Reading
CONTEXT: Relatively small scale RWE study (102 patients) on the variation in biomarker testing in NSCLC patients in the Netherlands. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 Continue Reading
